IRIS
PISANI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.009
EU - Europa 7.679
AS - Asia 3.857
SA - Sud America 1.804
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 101
OC - Oceania 11
Totale 21.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.826
RU - Federazione Russa 3.715
SG - Singapore 1.707
BR - Brasile 1.575
CN - Cina 1.056
IE - Irlanda 961
SE - Svezia 760
IT - Italia 558
HK - Hong Kong 441
UA - Ucraina 409
DE - Germania 396
FR - Francia 271
VN - Vietnam 202
FI - Finlandia 197
GB - Regno Unito 173
IN - India 101
AR - Argentina 79
CA - Canada 77
PL - Polonia 64
IQ - Iraq 50
TR - Turchia 50
MX - Messico 43
BD - Bangladesh 39
EC - Ecuador 37
NL - Olanda 36
AT - Austria 35
ZA - Sudafrica 29
BE - Belgio 28
UZ - Uzbekistan 26
CO - Colombia 24
MA - Marocco 24
JP - Giappone 23
PK - Pakistan 23
VE - Venezuela 20
ID - Indonesia 19
JM - Giamaica 19
CL - Cile 17
PY - Paraguay 17
PE - Perù 14
SA - Arabia Saudita 13
ES - Italia 12
LT - Lituania 10
OM - Oman 10
PH - Filippine 10
TN - Tunisia 10
BO - Bolivia 9
HN - Honduras 9
IR - Iran 9
JO - Giordania 9
PA - Panama 9
UY - Uruguay 9
CZ - Repubblica Ceca 8
KE - Kenya 8
KZ - Kazakistan 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
CR - Costa Rica 7
IL - Israele 7
CH - Svizzera 6
EG - Egitto 6
AZ - Azerbaigian 5
KR - Corea 5
RS - Serbia 5
DZ - Algeria 4
ET - Etiopia 4
GT - Guatemala 4
KG - Kirghizistan 4
LB - Libano 4
LV - Lettonia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EE - Estonia 3
EU - Europa 3
GR - Grecia 3
MY - Malesia 3
PS - Palestinian Territory 3
RO - Romania 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
KW - Kuwait 2
MK - Macedonia 2
NG - Nigeria 2
NP - Nepal 2
SI - Slovenia 2
SR - Suriname 2
Totale 21.443
Salva come PNG Salva come JPEG
Città #
Moscow 1.240
Dublin 958
Ashburn 850
Jacksonville 829
Singapore 807
Chandler 699
Dallas 529
Hong Kong 441
Beijing 389
San Jose 369
Nyköping 321
Council Bluffs 312
The Dalles 236
Dearborn 193
Princeton 189
Los Angeles 187
Cambridge 181
Lauterbourg 167
Des Moines 148
Medford 125
São Paulo 117
Ann Arbor 116
Boardman 98
New York 98
Buffalo 91
Ho Chi Minh City 85
Warsaw 59
Rio de Janeiro 57
Tianjin 54
Messina 51
Wilmington 49
Woodbridge 48
Atlanta 45
Munich 44
Santa Clara 41
Hanoi 40
San Mateo 40
Shenyang 40
Milan 39
Orem 39
Belo Horizonte 38
Houston 38
Rome 37
Guangzhou 36
Jinan 35
Phoenix 32
Redondo Beach 30
Nanjing 29
Chicago 28
Brooklyn 27
Brussels 27
Curitiba 27
Columbus 25
Denver 25
Frankfurt am Main 25
Montreal 24
Seattle 24
Vienna 24
Tashkent 23
Bremen 22
Pune 22
Salvador 22
Brasília 20
Hebei 20
Porto Alegre 20
Amsterdam 19
Campinas 19
Manchester 18
Stockholm 18
Tokyo 18
Chennai 17
Mumbai 17
Norwalk 16
Shanghai 16
Zhengzhou 16
Fortaleza 15
Guayaquil 15
Jiaxing 15
London 15
Ningbo 15
Shenzhen 15
Guarulhos 14
Hangzhou 14
Lancaster 14
Naples 14
Ribeirão Preto 14
Helsinki 13
Istanbul 13
Johannesburg 13
Poplar 13
Fuzhou 12
Haikou 12
Mexico City 12
Recife 12
San Francisco 12
Baghdad 11
Caruaru 11
Goiânia 11
Nuremberg 11
Sorocaba 11
Totale 11.602
Salva come PNG Salva come JPEG
Nome #
Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. 547
" Stato confusionale di probabile natura iatrogena"; " Verosimile screzio psicotico"; " Sindrome Cefalalgica"; " Disturbo d'Ansia". Varie ipotesi ed una sola diagnosi: SENC 459
Antiepileptic drugs and MTHFR Polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients 225
ALLOPURINOL AS ADD-ON THERAPY IN REFRACTORY EPILEPSY - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY 207
"Valproic acid-amitriptyline interaction in man 207
Hyperhomocysteinemia in patients with epilepsy: does it play a role in the pathogenesis of brain atrophy? A preliminary report. 199
ATTENTION CHARACTERIZATION IN PATIENTS WITH FRONTAL AND TEMPORAL LOBE EPILEPSY 198
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 195
beneficial effect of donezepil in a malnourished surgical patient with severe nonalcoholic wernicke's encephalopathy 189
Distribuzione di due polimorfismi genici della MTHFR in pazienti con Epilessia e correlazione con i livelli serici di omocisteina 187
Controllo totale di crisi con l’associazione lamotrigina-gabapentin in un caso di epilessia sintomatica. 183
Differential distribution of epilepsy in patients with different types of dementia: a single-centre, retrospective study 182
Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study 182
Non-convulsive status epilepticus after ischemic stroke: a hospital-based stroke cohort study 180
Rischio di iperomocisteinemia in pazienti con Epilessia, portatori del diplotipo C677T/A1298C della MTHFR 179
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 178
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 177
FORCED NORMALISATION: A RETROSPECTIVE ANALYSIS OF RISK FACTORS 176
Aspetti neuropsichiatrici dell'epilessia 176
A sensitive gas chromatograpic assay for the determination of serum viloxazine concetration using a nitrogen-phosphorus selective detector". Ther. Drug Monit., 6:484-488, 1984. 176
An epidemiological study of the clinical impact of pharmacokinetic anticonvulsant drug interactions based on serum drug level analysis 174
FORCED NORMALISATION: OBSERVATION WITH NEW ANTIEPILEPTIC DRUGS 171
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 170
Repetitive transcranial magnetic stimulation induced slow wave activity modification: A possible role in disorder of consciousness differential diagnosis? 167
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 166
A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats 163
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia 162
CARBAMAZEPINE VALNOCTAMIDE INTERACTION IN EPILEPTIC PATIENTS - IN-VITRO IN-VIVO CORRELATION 159
Effect of viloxazine on serum carbamazepine levels in epileptic patients 159
A critical role of NO/cGMP/PKG dependent pathway in hippocampal post-ischemic LTP: modulation by zonisamide 156
Is retinal assessment useful in epileptic patients with hyperhomocysteinemia? 155
Effects of psychotropic drugs on seizure threshold 154
Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropylacetamide 153
Carbamazepine-viloxazine interaction in patients with epilepsy 152
Diurnal fluctuations in plasma drug levels:studies with valproic acid and carbamazepine 149
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs 148
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 144
The contribution of inter-ictal SPECT in the evaluation of patients with epilepsy: Possible additional uses on the basis of selected cases [Il contributo della SPECT inter-critica nella valutazione del paziente con epilessia: Possibili ulteriori indicazioni sulla base di alcuni casi selezionati] 144
Accidents in patients with epilepsy: types, circumstances, and complications: a European cohort study 143
Antiepileptic drug comedications in clinical practice 143
THE EFFECT OF COMBINING VIGABATRIN AND TIAGABINE, TWO DRUGS WITH COMPLEMENTARY GABAERGIC MECHANISMS, AGAINST NMDA-INDUCED EXCITOTOXICITY 141
Identification of amoebae in the CSF in a patient with meningoencephalitis. 140
Attivita' parossistica ed agenti farmacologici: attivazione ed inibizione 140
COULD LAMOTRIGINE BE USEFUL IN STATUS EPILEPTICUS - A CASE- REPORT 138
Crisi epilettiche indotte dall’assunzione di leflunamide in pazienti in terapia con carbamazepina 138
Withdrawal of antiepileptic drugs: guidelines of the Italian League Against Epilepsy 137
Normalizzazione forzata e fattori di rischio: un'analisi retrospettiva 136
Differential interactions of valproic acid and valpromide with Carbamazepine in man 134
Prevenzione dell’epilettogenesi: revisione della letteratura, raccomandazioni terapeutiche, proposte di ricerca 134
Neuroprotective effects of levetiracetam against kainic acid toxicity are mediated by inhibition of lipid peroxidation 133
Disturbi del linguaggio e farmaci antiepilettici: analisi prospettica dei possibili fattori di rischio 132
Prime esperienze su efficacia e tollerabilità della tiagabina in pazienti con epilessia farmacoresistente 129
The effect of lamotrigine on peripheral nerves. 128
Meccanismi eccitotossici in un modello sperimentale in vitro: effetti della lamotrigina sul rilascio di amminoacidi eccitatori 127
CONTRIBUTION OF INTERICTAL BRAIN PERFUSION SPECT IN ASSESSING PATIENTS WITH EPILEPSY 126
Effetto della viloxazina sui livelli ematici di oxcarbazepina e dei relativi metaboliti 122
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico 121
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico. 120
Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs. 120
The 894G > T (Glu298Asp) variant in the endothelial NOSgene and MTHFR polymorphisms influence homocysteine levels in patients withcognitive decline. 119
INFLUENCE OF COMEDICATION ON THE METABOLISM OF VALPROATE 117
ELEVATION OF PLASMA PHENYTOIN BY VILOXAZINE IN EPILEPTIC PATIENTS - A CLINICALLY SIGNIFICANT DRUG-INTERACTION 116
Neuroprotective effect of remacemide hydrochloride against NMDA-induced excitotoxicity in isolated chick embryo retina 115
Ruolo dei farmaci antiepilettici nella neuroprotezione da ischemia cerebrale 115
Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T polymorphism in Levodopa-treated Parkinson’s disease patients 114
Specific Patient Features Affect Antiepileptic Drug Therapy Decisions: Focus on Gender, Age, and Psychiatric Comorbidities 114
INTERACTION OF LAMOTRIGINE WITH SODIUM VALPROATE 113
Il concetto di normalizzazione forzata in epilettologia 113
Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment 113
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients 112
Marcato effetto sinergico terapeutico dell'associazione lamotrigina-valproato in pazienti con epilessia farmaco-resistente 111
Effects of remacemide and lamotrigine on MNDA-induced excitotoxicity in isolated chick embryo retina 110
Liquid chromatographic assay of lamotrigine,a new antiepileptic drug, by a hig-speed column 109
Single-dose kinetics of primidone in acute viral hepatitis 109
Evaluation of Tricyclic Antidepressant Plasma Levels by an Automated Enzyme Immunoassay (EMIT) in Comparison to a High-Performance Liquid Chromatographic Method 109
Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis 109
Epilepsy Study Group of the Italian Neurological Society. Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis. 109
Efficacia della lamotrigina nelle crisi con caduta 108
Phenylethylmalonamide in essential tremor.A double-blind controlled study 107
Increased dipropylacetic acid bioavailability from dipropylacetamide by food 107
EFFECTS OF THE ANTIDEPRESSANT DRUG VILOXAZINE ON OXCARBAZEPINE AND ITS HYDROXYLATED METABOLITES IN PATIENTS WITH EPILEPSY 106
Pharmacokinetics and therapeutic plasma monitoring of antiepileptic drugs 106
The importance of drug interactions in epilepsy therapy 106
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 106
The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: Evidence for a pharmacodynamic interaction 105
Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia 105
Objective cognitive dysfunction assessment in patients with subjective cognitive complaints: does it allow an early differentiation between demnetia and pseudo-dementia? 104
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 103
Sodium valproate and valpromide:Differential interactions with carbamazepine in epileptic patients 103
VIGABATRIN-INDUCED DECREASE IN SERUM PHENYTOIN CONCENTRATION DOES NOT INVOLVE A CHANGE IN PHENYTOIN BIOAVAILABILITY 102
Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retina 102
Morbidity in patients with epilepsy: type and complications: a European cohort study 101
Valproic acid-ethosuximide interaction: A pharmacokinetic study 101
Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration 101
LAMOTRIGINE IN RESISTANT CHILDHOOD EPILEPSY 100
CLINICALLY RELEVANT ANTI-EPILEPTIC DRUG-INTERACTIONS 100
Intracellular calcium increase in epileptiform activity: Modulation by levetiracetam and lamotrigine 100
Interazione della carbamazepina con la valnoctamide: dati "in vitro" ed in pazienti con epilessia 100
Principles and current issues of antiepileptic drug therapy 98
THE INFLUENCE OF ELECTROENCEPHALOGRAPHIC FOCUS LATERALITY ON EFFICACY OF CARBAMAZEPINE IN COMPLEX PARTIAL AND SECONDARILY GENERALIZED TONIC-CLONIC SEIZURES 96
Totale 14.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.507
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022909 0 0 0 42 22 3 66 55 25 152 194 350
2022/20232.741 235 172 96 214 257 257 29 182 1.156 17 80 46
2023/2024637 68 122 60 69 46 130 15 26 2 29 8 62
2024/20253.325 55 45 89 154 158 75 41 962 867 151 188 540
2025/20268.572 268 615 572 764 692 2.129 989 1.029 992 276 109 137
2026/20271.826 187 402 524 713 0 0 0 0 0 0 0 0
Totale 21.565